Clinical and economic impact of molecular testing for BRAF fusion in pediatric low-grade Glioma

BACKGROUND: Treatment personalization via tumor molecular testing holds promise for improving outcomes for patients with pediatric low-grade glioma (PLGG). We evaluate the health economic impact of employing tumor molecular testing to guide treatment for patients diagnosed with PLGG, particularly th...

Descripción completa

Detalles Bibliográficos
Autores principales: Rios, Juan David, Velummailum, Russanthy, Bennett, Julie, Nobre, Liana, Tsang, Derek S., Bouffet, Eric, Hawkins, Cynthia, Tabori, Uri, Denburg, Avram, Pechlivanoglou, Petros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722113/
https://www.ncbi.nlm.nih.gov/pubmed/34980048
http://dx.doi.org/10.1186/s12887-021-03069-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722113/
https://www.ncbi.nlm.nih.gov/pubmed/34980048
http://dx.doi.org/10.1186/s12887-021-03069-1

Ejemplares similares